Quanterix Is Said to Near Deal for Akoya Biosciences (Correct)

Quanterix Corp. is in advanced talks to acquire life sciences peer Akoya Biosciences Inc. in an all-stock deal, according to people familiar with the matter, potentially combining two companies that detect diseases at different stages of progression.

A deal could be announced as soon Friday, the people said, asking to not be identified because the discussions aren’t public. The combined company’s equity will be worth about $670 million, the people said.

Representatives for Quanterix and Akoya declined to comment.

Akoya, whose shares have fallen 47% in the past year, last traded at $2.66 in New York, giving the company a ...